R.R. Donnelley & Sons Company (RRD) Social Stream

R.R. Donnelley & Sons Company (RRD): $10.84

0.00 (0.00%)

POWR Rating

Component Grades








Featured Post From StockTwits About RRD

Why do I invest in $ IBIO?
- No debt - could self finance Phase I
- Hiring like crazy
- Disrupting technology - cheap as hell
- New everything - management, team, website
- Covid-19 is not over - 1.19 billion fully vaccinated out of 8 billion
- IBio400 - almost there
- https://ibioinc.com/pipeline/

- Fraunhofer - undisclosed settlement portion
- Fraunhofer - Royalties coming
- IBio 201/202 - Successful Preclinical Studies
- https://ir.ibioinc.com/news-events/press-releases/detail/163/ibio-reports-successful-preclinical-immunization-studies

- Safi Biosolutions blood cell therapy products MSA
- https://www.globenewswire.com/news-release/2020/10/02/2102845/0/en/iBio-Enters-into-Agreement-with-Safi-Biosolutions-to-Develop-Growth-Factors-and-Cytokines-Using-the-FastPharming-System.html

- Selected by ATB Therapeutics to produce antibody toxin fusion proteins
- https://ibioinc.com/ibio-selected-to-produce-atb-therapeutics-bioengineered-antibody-toxin-fusion-proteins/

- Entered Oncology arena with three undisclosed targets (what’s with the suspense)
- https://ir.ibioinc.com/news-events/press-releases/detail/162/ibio-establishes-oncology-drug-discovery-pipeline-with

- At 1.28 the stock is grossly undervalued and heavily manipulated

Disclaimer: I’m not a financial advisor. Do your own DD b4 investing
IBIO_OB1, published August 8, 2021

What Else are RRD Traders Talking About?

Other tickers frequently mentioned alongside RRD is .

Loading social stream, please wait...

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!